logo

Rockwell Medical Technologies Inc (RMTI)



Trade RMTI now with
  Date
  Headline
11/11/2019 4:11:31 PM Rockwell Medical Q3 Loss/share $0.12 Vs. Loss $0.10 Year Ago
9/5/2019 4:34:51 PM Rockwell Medical John McLaughlin To Board Of Directors
8/6/2019 6:52:58 AM Rockwell Medical Reports Acceptance By FDA Of NDA For I.V. TRIFERIC
5/6/2019 6:55:39 AM Rockwell Medical Commences Commercial Sales Of Dialysate Triferic In The U.S.
3/14/2019 7:15:00 AM Rockwell Medical Q4 Net Loss $9.4 Mln Or $0.17/Shr Vs Loss Of $9.0 Mln Or $0.18/shr Last Year
11/9/2018 7:11:53 AM Rockwell Medical Q3 Net Loss $5.0 Mln Or $0.10/shr Vs Loss $5.1 Mln Or $0.10/Shr Last Year
11/1/2018 8:11:55 AM Rockwell Medical Appoints Angus Smith New CFO
9/4/2018 4:31:28 PM Rockwell Medical Appoints Jim McCarthy As SVP, Business And Corporate Development
8/8/2018 8:03:11 AM Rockwell Medical Appoints Stuart Paul As CEO, Effective Sept 4
8/7/2018 12:20:57 PM Rockwell Medical Enters Into Settlement With Chioini, Klema, Bagley And Boyd
7/16/2018 8:33:56 AM Calcitriol Contract Manufacturing Submission Gets FDA Approval; Allows Rockwell Medical Commercialization Of Calcitriol
6/29/2018 7:36:37 AM Rockwell Medical Provides Investor Update
6/7/2018 8:17:47 AM Rockwell Medical Expects Not To Receive Transitional Drug Add-On Payment Adjustment For Triferic In Near Term
5/8/2018 8:35:38 AM Rockwell Medical Updates On Calcitriol New Manufacturing Submission To FDA
3/20/2018 8:35:11 AM Rockwell Medical Reports Triferic Presentations At The 2018 Asia Pacific Congress Of Nephrology
  
 
>